Skip to main content
. 2022 Oct 17;11(20):6108. doi: 10.3390/jcm11206108
CKD chronic kidney disease
CKD-MBD chronic kidney disease associated mineral bone disorder
CNI calcineurin inhibitor
cPRA calculated panel reactive antibody
DSA donor specific antibody
ESA erythropoiesis stimulating agents
GFR glomerular filtration rate
GIS graft intolerance syndrome
HD hemodialysis
IS immunosuppression
KDIGO kidney disease improving global outcomes
KT kidney transplant
KRAFT the kidney recipient with allograft failure transition of care
PD peritoneal dialysis
PRA panel reactive antibody
RCT randomized clinical trial